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Nelumbo nucifera Gaertn (Nelumbonaceae) a plant used in Ayurvedic medicine (common name: lotus), is 
a perennial, large and rhizomatous aquatic herb most prevalent in South India. Preliminary phytochemical 
screening of both white and pink Nelumbo nucifera flowers revealed the presence of phytochemical 
constituents (flavonoids, alkaloids, phenols etc,). Hence, an attempt has been made to screen the effect of 
Nelumbo nucifera flowers (both types) on platelet aggregation. The antiplatelet activity of hydroethanolic 
extract of both types of flowers was studied using platelet-rich plasma in different concentrations (100-500µg/
ml). Both white and pink Nelumbo nucifera flower extracts showed dose-dependent effective antiplatelet 
activity with maximum activity at 500µg/ml concentration; prevention of platelet aggregation was 50% of 
that achieved with standard aspirin. Furthermore, the antiplatelet activity of white flowers was relatively 
high (p<0.05; ANOVA) compared to pink flowers. In conclusion, these observations suggest that both 
varieties of Nelumbo nucifera flower extracts exert different levels of inhibitory action on platelets in vitro 
(secretion and platelet aggregation suppression) due to differences in phytochemical content (alkaloids, 
flavonoids, phenols, tannins, phytosteroids, glycosides and saponins).
Uniterms: Nelumbo nucifera Gaertn./phytochemical constituents. Nelumbo nucifera Gaertn./pharmacognosy. 
Nelumbo nucifera Gaertn./Antiplatelet activity. Ayurvedic medicine. Natural products. Aspirin.
Nelumbo nucifera Gaertn (Nelumbonaceae, planta utilizada na medicina Ayurvédica, é erva aquática rizomatosa 
grande, predominante no sul da Índia. A triagem fitoquímica preliminar das flores brancas e cor-de-rosa de 
Nelumbo nucifera revelou a presença de constituintes fitoquímicos (flavonoides, alcaloides, fenóis etc). Assim, 
tentou-se a triagem do efeito das flores de Nelumbo nucifera de ambos os tipos na agregação plaquetária. A 
atividade antiplaquetária dos extratos hidroetanólico de ambos os tipos de flores foi estudada, utilizando-se 
plasma rico em plaquetas em duas diferentes concentrações (100 – 500 µg/mL). Tanto os extratos das flores 
brancas quanto daquelas de cor-de-rosa mostraram atividade antiplaquetária dose-dependente, com o máximo 
na concentração de 500 µg/mL. A prevenção da agregação plaquetária foi 50% daquela alcançada com o 
padrão de ácido acetilsalicílico. Além disso, a atividade antiplaquetária das flores brancas foi, relativamente, 
alta (p<0,05; ANOVA), comparativamente às flores cor-de-rosa. Estas observações sugerem que ambas as 
variedades de extratos de flores de Nelumbo nucifera exercem diferentes níveis de ação inibitória nas plaquetas 
in vitro (supressão da secreção e da agregação plaquetária) devido a diferentes constituintes fitoquímicos 
(alcaloides, flavonoides, fenóis, taninos, fitoesteróides, glicosídeos e saponinas).
Unitermos: Nelumbo nucifera Gaertn./constituintes fitoquímicos. Nelumbo nucifera Gaertn./farmacognosia. 
Nelumbo nucifera Gaertn./atividade antiplaquetária. Medicina Ayurvédica. Produtos naturais. Ácido 
acetilsalicílico.
INTRODUCTION
Platelets play a prominent role in homeostasis and 
thrombosis. The normal haemostatic system limits blood 
loss by regulated interactions between components of 
vessel wall, circulating blood platelets and plasma proteins 
(Saengkhae et al., 2008). Platelets can adhere to the walls 
of the blood vessels, release bioreactive compounds and 
aggregate to each other. These properties increase to a well 
established level in conditions of arterial thrombosis and 
atherogenesis (Guyton, 1991).
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Several antiplatelet drugs have been developed to 
inhibit platelet activity in acute thrombotic situations as 
well as to prevent adverse events. Antiplatelet therapy is 
one of the most effective therapies for treatment of athe-
rothrombotic disease. Considering the recently proved 
role of platelets in atherosclerosis the long-term use of 
antiplatelet drugs could also be postulated to slow down 
progression of the disease (Olas et al., 2005). Therefore, 
the compounds that inhibit platelet function are of great 
interest, and it has also been shown that some plants, such 
as garlic and tomato may be beneficial in protecting against 
cardiovascular diseases as a result of platelet aggregation 
inhibition. Medicinal plants are rich in bioactive compoun-
ds (flavonoids, polyphenolic, vitamins and carotenoids) 
which inhibit platelet function (Olas et al., 2005). 
Nelumbo nucifera Gaertn (Nelumbonaceae), com-
monly known as Indian lotus, have been widely used in 
folk medicine for the treatment of various inflammatory 
and infectious diseases (Liu et al., 2004). Studies using in 
vitro and in vivo models have demonstrated that this plant 
has antidiabetic, antipyretic, anti-inflammatory, antican-
cerous, antimicrobial, antiviral and anti-obesity properties 
(Kashiwada et al., 2005). Furthermore, Nelumbo nucifera 
flowers are served as healthy beverages to treat hyperten-
sion, cancer, diarrhea, fever, weakness, infection and body 
heat imbalance (Saengkhae et al., 2008).
The major constituents isolated from the lotus plant 
are alkaloids (liensinine, neferine, nuciferine, remrefidine 
and isoliensinine) and flavonoids ((+)-1(R)-coclaurine, 
(-)-1(S)-norcoclaurine and quercetin 3-O-b-D-glucuro-
nide) (Sridhar and Rajeev, 2007). One of the most potent 
mechanisms by which flavonoids inhibit platelet aggrega-
tion is by mediating increase in platelet cyclic AMP levels 
by either stimulation of adenylate cyclase or inhibition of 
cAMP phosphodiesterase activity (Iman et al., 2009). The 
composition of flavonoids, polyphenols, alkaloids and 
natural antioxidants present in pink and white flowers is 
completely different (Iman et al., 2009). Therefore the pre-
sent study was designed to evaluate the antiplatelet activity 
of hydroethanolic extract of white and pink Nelumbo nu-
cifera flowers (phytochemical composition is different in 
both varieties) and to elucidate the inhibitory mechanisms 
of flavonoids in platelet aggregation. Furthermore, it is a 
well-known fact that many patients taking aspirin conti-
nue to have adverse cardiovascular events. One potential 
explanation for aspirin failure is variable response of 
individual patients to aspirin with consequent inadequate 
platelet inhibition. Previous studies have estimated that 
adequate anti-platelet effect is not achieved in 0.4 - 35% 
patients taking aspirin, leading to increased occurrence of 
cardiovascular diseases (Eikelboom et al., 2002). Hence, 
there is a need to seek medicinal plants and their natural 
constituents which show minimal side effects. It is in this 
context the present study is carried out.
MATERIALS AND METHODS
Plant material
The flowers of Nelumbo nucifera were collected 
from different localities of Coimbatore District, Tamil 
Nadu in September 2008 and authenticated by the Bota-
nical Survey of India (BSI) in “Tamil Nadu Agriculture 
University” Coimbatore, Tamil Nadu, India. A voucher 
specimen (No.BSI/SC/5/23/09-10/Tech.279 MH) has been 
deposited at the Herbarium of the Botany department of 
“Tamil Nadu Agriculture University” for future reference. 
Plant extraction
The air-dried and powdered flowers (100g each) 
were cold macerated with 50% ethanol for 3 days, with 
occasional stirring. After 3 days, the suspension was fil-
tered through a fine muslin cloth and was evaporated to 
dryness at low temperature (< 40ºC) under reduced pres-
sure in a rotary evaporator. Dark brown colored crystals 
of approximately 8g were stored in an air-tight dessicator 
and used for further analysis. 
Phytochemical screening
Qualitative phytochemical screening of both white 
and pink Nelumbo nucifera flowers of different solvent 
extracts was carried out (Khandelwal, 2002) to test for 
the presence of secondary metabolites including alkaloi-
ds, flavonoids, phenols, tannins, steroids, glycosides and 
saponins. 
Antiplatelet activity
Platelet-rich plasma and Tyrode buffer were used 
for the antiplatelet activity according to Iman et al. 
(2009). Platelet-rich plasma (PRP) was prepared by cen-
trifugation of citrated blood at 22°C for 6min, at 400g. 
Platelets were adjusted to 3.0×108 cell/ml with sterile 
saline. Tyrode buffer was prepared using sodium chloride 
149mM, potassium chloride 2.6mM, sodium bicarbonate 
9.5mM, glucose 5.5mM, sodium dihydrogen phosphate 
0.5mM, magnesium chloride 0.6mM and gelatin 0.25%. 
The platelet-rich plasma 0.13 × 10-7 for each assay was 
resuspended in Tyrode buffer (pH adjusted to 7.4 with 
0.25 M Hcl). Aggregation of the platelets was induced by 
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CaCl2 at a final concentration of 2μM. Platelet aggregation 
was recorded by increasing transmittance value of spec-
trophotometric measurements. To determine the in vitro 
antiplatelet aggregation property, different concentrations 
(100, 200, 300, 400 and 500µg/ml) of plant extract were 
added to the platelet suspension for 1min exposure at 37ºC 
before treatment with platelet aggregating agents. Aspirin 
at 500µg/ml was used as a standard.
RESULTS AND DISCUSSION
Platelet dysfunction contributes to the development 
and progression of many cardiovascular diseases such as 
arterial hypertension, atherosclerosis and thrombosis. In-
deed, it has been reported that patients with hypertension 
or coronary heart disease tend to have increased platelet 
reactivity. Therefore, many investigations were carried 
out toward the prevention of the abnormal hyperactivity 
of platelets reported in cardiovascular disorders employing 
different therapies, including use of medicinal plants 
(Massberg et al., 2005). The objective of the present study 
was to determine whether both white and pink Nelumbo 
nucifera flower extracts would affect platelet function and 
blood coagulation.
The preliminary phytochemical screening is shown 
in Tables I and II. From the results it was evident that 
all the solvent extracts were found to contain selected 
analysed phytochemicals. When compared with different 
solvent extracts, hydroethanolic extract was found to 
contain major active phytoconstituents such as alkaloids, 
flavonoids, phenols, tannins, steroids, glycosides and sapo-
nins screened in both white and pink flowers of the plant. 
In white flowers, relatively higher amounts of phytoche-
micals were present (Tables 1 and II). In hydroethanolic 
extract (used in the present study) the phytochemicals are 
present in relatively higher amounts in white flowers. (Ta-
bles I and II). These results are in accordance with Babayi 
et al. (2004) who reported that the phytochemical analysis 
of the crude extracts of Eucalyptus revealed the presence 
of saponin, glycosides, steroid, tannins and phenols. 
From Figures 1 and 2 it is evident that both white and 
pink Nelumbo nucifera flower extracts showed effective 
antiplatelet activity in a dose-dependent manner with ma-
ximum activity at 500µg/ml concentration. Furthermore, 
the antiplatelet activity of white flowers was relatively 
high (p<0.05; ANOVA) compared to the pink flowers. 
However, prevention of platelet aggregation was lower 
compared to standard aspirin at 500µg/ml concentration. 
The flavonoids present in hydroethanolic extract might 
have prevented the adhesion and aggregation of platelets 
besides release of cytoplasmic calcium that stimulates the 
release of ADP. These results are in accordance with those 
of other studies demonstrating that flavonoid compounds 
isolated from many plants, including the Solidago species, 
inhibit platelet aggregation (Koleckar et al., 2008).
There are numerous pathways leading to platelet 
aggregation. Prostaglandins (PG) and serotonin (5-HT) 
are considered the major chemical mediators of platelet 
aggregation (Ogawa et al., 1998). The clinical study of 
platelet aggregation reveals that both lotus flower extracts 
TABLE I - Phytochemical screening of white Nelumbo nucifera flowers in different solvent extracts
S.No Extract Alkaloids Flavonoids Phenols Tannins Steroids Glycosides Saponins
1. 50%Ethanol ++ ++ ++ + + ++ –
2. Benzene + ++ + + – + –
3. Chloroform + – + ++ + ++ +
4. Petroleum ether ++ + – + + – +
5. Water + + – – + – +
TABLE II - Phytochemical screening of pink Nelumbo nucifera flowers in different solvent extracts
S.No Extract Alkaloids Flavonoids Phenols Tannins Steroids Glycosides Saponins
1. 50%Ethanol + + + + + + –
2. Benzene + – + + – + –
3. Chloroform – + – – + + +
4. Petroleum ether – + – – + – –
5. Water + + – – – – –
+ Presence; – Absence
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FIGURE 1 - Antiplatelet activity of hydroethanolic extract of white Nelumbo nucifera flower extract 
(♦) antiplatelet activity of Aspirin at 500 µg/mL; (È) antiplatelet activity of hydroethanolic extract of white flower extract at 
100 µg/mL; (▲) antiplatelet activity of hydroethanolic extract of white flower extract at 200 µg/mL; (■) antiplatelet activity of 
hydroethanolic extract of white flower extract at 300 µg/mL; (Û) antiplatelet activity of hydroethanolic extract of white flower 
extract at 400 µg/mL; (●) antiplatelet activity of hydroethanolic extract of white flower extract at 500 µg/mL.
FIGURE 2 - Antiplatelet activity of hydroethanolic extract of pink Nelumbo nucifera flower extract 
(♦) antiplatelet activity of Aspirin at 500 µg/mL; (È) antiplatelet activity of hydroethanolic extract of pink flower extract at 
100 µg/mL; (▲) antiplatelet activity of hydroethanolic extract of pink flower extract at 200 µg/mL; (■) antiplatelet activity of 
hydroethanolic extract of pink flower extract at 300 µg/mL; (Û) antiplatelet activity of hydroethanolic extract of pink flower extract 
at 400 µg/mL; (●) antiplatelet activity of hydroethanolic extract of pink flower extract at 500 µg/mL.
can either inhibit the PG synthesis pathway of 5-HT rele-
ase. In addition, other studies have also demonstrated that 
saponins are effective in inhibiting platelet aggregation 
induced by ADP, by blocking the receptor-dependent Ca2+ 
influx of human platelets and/or inhibiting the production 
of leukotriene (Zeng et al., 2004). 
CONCLUSION
The obtained data indicated that the hydroethanolic 
extracts of both white and pink Nelumbo nucifera flowers 
possess potent antiplatelet activity limited to primary 
haemostasis in human blood. In addition, the antiplatelet 
activity of white flowers is relatively high compared to the 
pink flowers due to different composition of phytochemi-
cals. However, further studies are needed to confirm the 
mode of action and efficacy of both Nelumbo nucifera 
flower extracts in platelet aggregation.
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